Europe — EMA
Panzyga (Human Normal Immunoglobulin)
Human Normal Immunoglobulin, the active ingredient in Panzyga, is an immunoglobulin presented as a 10% solution for intravenous use. It treats primary immunodeficiency diseases and provides antibody replacement therapy…
Request sourcing
What is Human Normal Immunoglobulin?
Human Normal Immunoglobulin, the active ingredient in Panzyga, is an immunoglobulin presented as a 10% solution for intravenous use. It treats primary immunodeficiency diseases and provides antibody replacement therapy in patients with insufficient immune response. GNH USA supplies Panzyga as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.
GNH USA supplies Panzyga as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.
What is Human Normal Immunoglobulin used for?
Panzyga is an immunoglobulin therapy that replaces deficient antibodies in primary immunodeficiency disorders. - Primary immunodeficiency disease (PID): Restores normal levels of IgG antibodies to reduce infection frequency. - Secondary immunodeficiency (e.g., chronic lymphocytic leukemia‑related): Provides passive immunity to help prevent prevent the ... . - Post‑trans ....
